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Abstract
Objectives: This study was designed to evaluate the interaction between aging and obesity on cardiac contractile and
intracellular Ca
2+ properties.
Methods: Cardiomyocytes from young (4-mo) and aging (12- and 18-mo) male lean and the leptin deficient ob/ob obese
mice were treated with leptin (0.5, 1.0 and 50 nM) for 4 hrs in vitro. High fat diet (45% calorie from fat) and the leptin
receptor mutant db/db obesity models at young and older age were used for comparison. Cardiomyocyte contractile and
intracellular Ca
2+ properties were evaluated including peak shortening (PS), maximal velocity of shortening/relengthening
(6 dL/dt), time-to-PS (TPS), time-to-90% relengthening (TR90), intracellular Ca
2+ levels and decay. O2
2 levels were measured
by dihydroethidium fluorescence.
Results: Our results revealed reduced survival in ob/ob mice. Aging and obesity reduced PS, 6 dL/dt, intracellular Ca
2+ rise,
prolonged TR90 and intracellular Ca
2+ decay, enhanced O2
2 production and p
47phox expression without an additive effect of
the two, with the exception of intracellular Ca
2+ rise. Western blot analysis exhibited reduced Ob-R expression and STAT-3
phosphorylation in both young and aging ob/ob mice, which was restored by leptin. Aging and obesity reduced
phosphorylation of Akt, eNOS and p38 while promoting pJNK and pIkB. Low levels of leptin reconciled contractile,
intracellular Ca
2+ and cell signaling defects as well as O2
2 production and p
47phox upregulation in young but not aging ob/
ob mice. High level of leptin (50 nM) compromised contractile and intracellular Ca
2+ response as well as O2
2 production and
stress signaling in all groups. High fat diet-induced and db/db obesity displayed somewhat comparable aging-induced
mechanical but not leptin response.
Conclusions: Taken together, our data suggest that aging and obesity compromise cardiac contractile function possibly via
phosphorylation of Akt, eNOS and stress signaling-associated O2
2 release.
Citation: Ren J, Dong F, Cai G-J, Zhao P, Nunn JM, et al. (2010) Interaction between Age and Obesity on Cardiomyocyte Contractile Function: Role of Leptin and
Stress Signaling. PLoS ONE 5(4): e10085. doi:10.1371/journal.pone.0010085
Editor: Jose A. L. Calbet, University of Las Palmas de Gran Canaria, Spain
Received May 28, 2009; Accepted March 17, 2010; Published April 9, 2010
Copyright:  2010 Ren et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by grants from the American Heart Association Pacific Mountain Affiliate (#0355521Z), American Diabetes Association
(7-08-RA-130) and National Institutes of Health/National Center for Research Resources (NIH/NCRR) North Rockies Regional INBRE (P20 RR 016474) to J.R. The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jren@uwyo.edu (JR); jmpei8@fmmu.edu.cn (JP)
Introduction
Obesity is a devastating health problem afflicting all ages, races
and socioeconomic classes in both genders. Over the past decade,
only modest success has been achieved in combating the escalating
prevalence of obesity and metabolic syndrome [1,2]. The current
obesity epidemic may be attributed to many factors including
environmental (e.g., caloric and nutrient intake), genetic and even
evolutionary (e.g., interaction between human biology and human
culture over the long period of human evolution) [1,3]. With
today’s prolonged human lifespan, aging has also been considered
as an obesogenic factor given the increased visceral fat associated
with aging [4]. Paradoxically, visceral fat accumulation may in
turn influence longevity, thus prompting the speculation that
obesity could be a condition of premature aging [4]. Although
effective physiological adjustments are present to counterbalance
the potentially detrimental health outcome of obesity such as
altered respiratory mechanical/muscular function peculiar to the
aging condition [5], a number of obesity-associated comorbidities
such as cancer, endocrine, cardiovascular and immune disorders
may ultimately contribute to premature aging and the shortened
lifespan. Therefore, the concept of health promotion, especially on
nutrition and life style, has become an important part of health
care in older adults [6].
Among a wide array of comorbidities associated with obesity
including type 2 diabetes, hypertension, cancer and sleep apnea
[1], heart disease, which is mainly manifested by cardiac
hypertrophy and compromised ventricular function, may lead to
heart failure or premature death [7–9]. The pathophysiological
alterations associated with establishing and perpetuating obesity-
induced heart disease are complex but are becoming more clear,
including the interaction of sympathetic overactivation and
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pathophysiology of human obesity, several rodent models of
obesity have been developed and implemented including high fat
diet feeding and spontaneous mutants of the 16 KD obesity gene
product leptin or its receptor such as ob/ob and db/db mice. A
common feature of these obese animal models is the overtly
compromised cardiac contractile function associated with a
marked increase in visceral fat and hyperinsulinemia [11–14],
similar to human obesity. Accumulating evidence has also
implicated a role of the obese gene product leptin, which regulates
food intake and energy expenditure, in the regulation of cardiac
function, while the disruption of which contributes to obesity-
associated cardiac contractile and morphometric defects [15,16].
Human circulating leptin levels are elevated in obesity, vascular
and coronary heart diseases, favoring a contemporary perception
of hyperleptinemia being an independent risk factor for cardio-
vascular diseases [16,17]. This notion is further supported by the
experimental evidence that leptin may contribute to cardiac
hypertrophy, atherosclerosis and thrombosis possibly through
accumulation of reactive oxygen species [16,18,19]. Elevated
leptin level or hyperleptinemia is correlated with hyperphagia,
insulin resistance, hyperlipidemia and hypertension, independent
of total adiposity [16]. Data from our lab revealed that leptin
directly suppresses cardiomyocyte contraction and intracellular
Ca
2+ handling through mechanism(s) related to endothelial nitric
oxide synthase (eNOS), superoxide (O2
2) production, activation of
Janus kinase (JAK)/signal transducer and activator of transcription
(STAT) and stress signaling pathways including Jun N-terminal
kinase (JNK) and p38 mitogen-activated protein (MAP) kinase
[20–22]. Further evidence from our lab as well as others also
indicated that leptin deficiency paradoxically triggers cardiac
hypertrophy and contractile dysfunction in ob/ob obese mice with
a mutant leptin gene, the effect of which is reconciled by leptin
supplementation [12,15]. Both hyperleptinemia and leptin-defi-
ciency have been shown to be associated with increased apoptosis,
DNA damage and mortality, suggesting a potential association
between leptin signaling and aging-related DNA damage and
premature death [23]. Nevertheless, the interaction between
obesity and aging on cardiac function, with a focus on leptin
signaling, has not been elaborated. Given the prevalence of
metabolic syndrome in older adults and the detrimental impact of
metabolic syndrome especially obesity on life expectancy and
comorbidity in the elderly [24], the present study was designed to
evaluate the influence of aging on basal and leptin-elicited cardiac
contractile response in the leptin-deficient ob/ob mice. Expression
and activation of the leptin receptor Ob-R and post-receptor
signaling STAT-3, O2
2 producing enzyme NADPH oxidase
(p
47phox subunit) [25], Akt, eNOS, AMP-activated kinase (AMPK)
and the stress signaling molecules p38 MAP kinase, JNK,
extracellular signaling regulated kinase (ERK) and NFkB were
also examined in young and aging lean C57 and ob/ob leptin
deficient obese mice. Twelve- and eighteen-month-old mice were
chosen for the aging group largely due to the reduced lifespan and
high mortality seen after one year of age in ob/ob mice [26].
Cardiomyocyte contractile function was also examined in the high
fat diet-induced and the leptin receptor mutant hyperleptinemic
db/db obesity models for comparison.
Materials and Methods
Experimental animals and high fat diet feeding
All animal procedures were conducted in accordance with
humane animal care standards outlined in NIH Guide for the
Care and Use of Experimental and were approved by the
University of Wyoming and University of North Dakota Animal
Care and Use Committees. In brief, young (4-month-old) and
aging (12- or 18-month-old) male homozygous B6.V-lep,ob./J
leptin deficient ob/ob and B6.Cg-m +/+ Leprdb/J leptin receptor
mutant db/db obese mice were housed in our institutional animal
facilities. Age- and gender-matched wild-type C57BL/6J mice
were used as lean controls. All animals were allowed free access to
standard lab chow and tap water. For high fat diet-induced obesity
model, 4- and 12-month-old male C57BL/6J mice (4 per group)
were randomly assigned to a low fat (10% of total calorie) or a high
fat (45% of total calorie) diet (Research Diets Inc., New Brunswick,
NJ, USA) for 16 weeks [13]. Blood glucose was monitored with a
glucometer (Accu-ChekII, model 792, Boehringer Mannheim
Diagnostics, Indianapolis, IN, USA). All mice used for lifespan
analysis (the Kaplan-Meier survival curve and log-rank test) were
assigned to a longevity cohort at birth and were not used for any
biochemical, immunoblotting or mechanical function tests. Only
male mice were used for this study.
Body fat composition measurement
Body composition was measured using Dual Energy X-ray
Absorptiometry (DEXA), which is a clinical measure of lean tissue
mass, adipose tissue mass, and bone mineral mass and density. A
low level pencil-beam x-ray moved transversely from the head to
the tail across the sedated mouse. Difference in absorbance of the
X-ray was detected according to tissue density. Percent fat was
calculated using fat and body mass [27].
Cardiomyocyte isolation and in vitro leptin treatment
Mouse hearts were removed under anesthesia (ketamine/
xylazine at 3:1, 1.32 mg/kg) and were perfused with oxygenated
(5% CO2–95% O2) Krebs-Henseleit bicarbonate (KHB) buffer
containing (in mmol/L) 118 NaCl, 4.7 KCl, 1.25 CaCl2, 1.2
MgSO4, 1.2 KH2PO4, 25 NaHCO3, 10 HEPES, and 11.1
glucose. Hearts were perfused with a Ca
2+-free KHB containing
Liberase Blendzyme 4 (Hoffmann-La Roche Inc., Indianapolis,
IN, USA) for 20 min. After perfusion, left ventricles were removed
and minced to disperse cardiomyocytes in Ca
2+-free KHB buffer.
Extracellular Ca
2+ was added incrementally back up to 1.25 mM
[12]. Myocyte yield was ,75% which was not affected by obesity
or age. Cohorts of cardiomyocytes were incubated with leptin (0.5,
1.0 and 50 nM) for 4 hrs in a serum-free defined medium
consisting of Medium 199 (Sigma) with Earle’s salts. The
concentrations of leptin were chosen to cover physiological (0.5
and 1.0 nM) as well as pharmacological levels [16,22,28].
Cardiomyocytes with obvious sarcolemmal blebs or spontaneous
contractions were not used for mechanical recording.
Cell shortening/relengthening
Mechanical properties of cardiomyocytes were assessed using a
SoftEdge MyoCamH system (IonOptix Corporation, Milton, MA,
USA) [12]. In brief, cardiomyocytes were placed in a chamber
mounted on the stage of an inverted microscope (Olympus
Incorporation, Model IX-70, Tokyo, Japan) and superfused at
25uC with a buffer containing (in mM): 131 NaCl, 4 KCl, 1
CaCl2, 1 MgCl2, 10 glucose, 10 HEPES, at pH 7.4. The cells were
field stimulated with suprathreshold voltage (150% of the
threshold voltage of cell contraction) at a frequency of 0.5 Hz,
3 msec duration, using a pair of platinum wires placed on opposite
sides of the chamber connected to a FHC stimulator (Brunswick,
NE, USA). The myocyte being studied was displayed on a
computer monitor using an IonOptix MyoCam camera. An
IonOptix SoftEdge software was used to capture changes in cell
length during shortening and relengthening. Cell shortening and
Obesity, Age, Cardiac Function
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shortening (PS), the amplitude myocytes shortened upon electrical
stimulation, an indicative of peak ventricular contractility; time-to-
PS (TPS), the duration of myocyte shortening, an indicative of
systolic duration; time-to-90% relengthening (TR90), the duration
to reach 90% relengthening, an indicative of diastolic duration
(90% rather 100% relengthening was used to avoid noisy signal at
baseline level); and maximal velocities of shortening/relengthen-
ing, maximal slope (derivative) of shortening and relengthening
phases, indicatives of maximal velocities of ventricular pressure
increase/decrease.
Intracellular Ca
2+ transient measurement
Intracellular Ca
2+ was measured using a dual-excitation, single-
emission photomultiplier system (IonOptix) in myocytes loaded
with Fura-2-AM (0.5 mM). Myocytes were placed on an inverted
microscope and imaged through an Olympus (IX-70) Fluor 640
oil objective. Myocytes were exposed to light emitted by a 75-W
halogen lamp through either a 360- or 380-nm filter while being
stimulated to contract at 0.5 Hz. Fluorescence emissions were
detected between 480 and 520 nm by a photomultiplier tube after
initial illumination at 360 nm for 0.5 s and then at 380 nm for the
duration of the recording protocol. The 360-nm excitation reading
was repeated at the end of the protocol. Qualitative evaluation of
intracellular Ca
2+ was inferred from fluorescence intensity
changes. Myocyte shortening was also evaluated in a cohort of
the fura-2-loaded ventricular myocytes simultaneously to compare
their temporal relationship with the fluorescence signal. However,
their mechanical properties were not used for data summary due
to the apparent Ca
2+ buffering effect of fura-2 [12].
Western blot analysis
Following leptin treatment, cardiomyocytes from young and
aging C57 and ob/ob mice were collected and sonicated in a lysis
buffer containing 20 mM Tris (pH 7.4), 150 mM NaCl, 1 mM
EDTA, 1 mM EGTA, 1% Triton, 0.1% SDS and protease
inhibitor cocktail. The protein concentration of the supernatant
was evaluated using the protein assay reagent (Bio-Rad, Hercules,
CA, USA). Equal-amounts (30 mg) of protein and prestained
molecular weight marker (GIBCO, Gaithersburg, MD, USA) were
loaded onto 7%,10% SDS-polyacrylamide gels in a minigel
apparatus (Mini-PROTEAN II, Bio-Rad), separated, and trans-
ferred to nitrocellulose membranes (0.2 mm pore size, Bio-Rad).
Membranes were incubated for 1 hr in a blocking solution
containing 5% nonfat milk in TBS-T before being washed in TBS-
T. Membranes were then incubated overnight at 4uC with anti-
p47
phox (1:1000, kindly provided by Dr. Mark T. Quinn from
Montana State University, Bozeman, MT), anti-p38 MAP kinase
and anti-phospho-p38 MAP kinase (pp38, 1:1,000), anti-ERK
(1:1,000;), anti-phospho-ERK (pERK; 1:1,000), anti-SAPK/JNK
(1:1,000), anti-phospho-SAPK/JNK (pJNK, 1:1,000), anti-IkB
(1:1,000), anti-phospho-IkB( p I kB, 1:1,000), anti-Akt (1:1,000),
anti-phospho-Akt (pAkt, 1:1,000), anti-eNOS, anti-phospho-eNOS
(peNOS, 1:1000), anti-STAT3 (1:1,000), anti-phospho-STAT3
(pSTAT3, 1:1,000), anti-Ob-R (long form isoform Ob-Rb, 1:1000),
anti-AMPK (1:1000) and anti-phospho-AMPK (pAMPK,1:1000)
antibodies. GAPDH was used as the internal loading control
(1:5,000). All antibodies were obtained from Cell Signaling
Technology (Beverly, MA, USA) or Santa Cruz Biotechnology
(Santa Cruz, CA, USA) unless otherwise specified. After incubation
with the primary antibodies, blots were incubated with either anti-
mouse or anti-rabbit IgG horseradish peroxidase-linked antibodies
at a dilution of 1:5,000 for 60 min at room temperature.
Immunoreactive bands were detected using the Super Signal West
Dura Extended Duration Substrate (Pierce, Milwaukee, WI).
Intensity of the bands was measured with a scanning densitometer
(model GS-800; Bio-Rad) coupled with Bio-Rad personal
computer analysis software.
Intracellular fluorescence measurement of superoxide
(O2
2)
Intracellular superoxide were monitored by changes in
fluorescence intensity resulting from intracellular probe oxidation
according to a previously described method [22]. Following leptin
(0.5, 1.0 and 50 nM) treatment, cardiomyocytes from young and
aging C57 lean and ob/ob mice were loaded with 5 mM
dihydroethidium (DHE) (Molecular Probes, Eugene, OR, USA)
for 30 min at 37uC and washed with PBS buffer. Cells were
sampled randomly using an Olympus BX-51 microscope equipped
with an Olympus MagnaFire
TM SP digital camera and ImagePro
image analysis software (Media Cybernetics, Silver Spring, MD).
Fluorescence was calibrated with InSpeck microspheres (Molec-
ular Probes). More than 150 cells per group were evaluated using
the grid crossing method for cell selection in more than 15 visual
fields per experiment.
Statistical analysis
Data are presented as mean 6 SEM. Statistical significance
(p,0.05) was determined by a one- or two-way analysis of
variance (ANOVA) followed by a Tukey’s post hoc analysis.
Results
General features of experimental animals
As expected, young ob/ob mice displayed significantly greater
body, heart, liver and kidney weights compared with age-matched
young C57 mice. The organ size (when normalized to tibial length)
was also significantly greater in young ob/ob mice compared with
the young C57 group. Body and organ (except kidney in aging ob/
ob mice) weights were significantly heavier in aging (12-month-old)
C57 or ob/ob mice compared with respective young groups, as
expected. Consistently, the organ size (normalized to tibial length)
was significantly greater in the 12-month-old aging C57 mice
compared with young C57 mice. Nonetheless, liver size but not
that of heart and kidney was significantly enhanced with aging in
ob/ob mice. Body fat composition was significantly elevated with
aging and obesity, with an additive effect between the two. There
were no significant differences in tibial length and fasting glucose
levels among the four mouse groups, excluding growth-related
factor and the presence of full-blown diabetes mellitus (Table 1).
The 18-month-old C57 and ob/ob mice displayed a comparable
biometric profile somewhat similar to their 12-month-old
counterparts (data not shown). The Kaplan-Meier survival curve
comparison depicts that ob/ob mice display significantly reduced
survival rates when compared to C57 lean mice. The median
lifespan was 27.0 and 18.0 months for C57 and ob/ob mice,
respectively (p=0.0007). Survival curves of the two mouse groups
began to separate after ,6 months of age with ob/ob mice
exhibiting a greater mortality rate (Fig. 1).
Mechanical and intracellular Ca
2+ properties of
cardiomyocytes in ob/ob obesity
Neither obesity nor aging significantly affected the myocyte
yield or overall appearance (Fig. 2). The resting cell length was
significantly greater in young ob/ob and aging (both 12 and 18
months of age) C57 mice compared with young C57 mice. Obesity
further augmented aging-elicited elongation in cardiomyocyte
Obesity, Age, Cardiac Function
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leptin treatment did not affect resting cell length in either young or
aging C57 and ob/ob mice (Fig. 3A). Both obesity and aging (12
and 18 months) significantly reduced peak shortening (PS)
amplitude and maximal velocity of shortening/relengthening
(6 dL/dt), prolonged time-to-90% relengthening (TR90) without
affecting time-to-peak shortening (TPS). There was little difference
in the aging-induced change in mechanical parameters between 12
and 18 months of age. In addition, there was no discernible
synergistic effect between obesity and age on these mechanical
indices. Leptin supplementation at physiological levels (0.5 and
1.0 nM) effectively nullified obesity-induced mechanical deficien-
cies (PS, 6 dL/dt and TR90) in young but not aging (12-month)
mouse groups. However, leptin treatment (0.5 and 1.0 nM) did
not alter aging-induced mechanical changes in PS, 6 dL/dt and
TR90 (Fig. 3B-3F). Consistent with our previous report [22],
pharmacological level of leptin (50 nM) overtly impaired cardio-
myocyte mechanical function including depressed PS and 6 dL/
dt as well as prolonged TPS and TR90 in both young and aging
C57 or ob/ob mouse groups (Fig. 3A–3F). To explore the possible
role of intracellular Ca
2+ homeostasis in obesity and/or aging-
induced mechanical responses, we evaluated intracellular Ca
2+
transients using the Fura-2 fluorescence measurement. Our results
indicated that both obesity and aging enhanced resting intracel-
lular Ca
2+ levels without any additive effects. The rise of
intracellular Ca
2+ in response to electrical stimuli was significantly
reduced by either obesity or aging (12- and 18-month) with an
Table 1. General features of young (4-month-old) or aging (12-month-old) lean C57 and ob/ob mice.
C57-young C57-aging ob/ob-young ob/ob-aging
Body Weight (g) 24.060.5 29.060.5* 54.360.9** 63.662.9*,**
Heart Weight (mg) 14463 17863* 31665** 35068*,**
Tibial Length (mm) 16.660.2 17.060.2 16.560.2 17.160.3
HW/TL (mg/mm) 8.6660.19 10.460.2* 19.160.3** 20.560.5**
Liver Weight (g) 1.2860.08 1.5860.07* 3.1260.13** 4.5860.17*,**
LW/TL (mg/mm) 77.264.8 92.564.2* 189.367.6** 267.869.9*,**
Kidney Weight (g) 0.2760.02 0.3760.02* 0.4660.02** 0.4960.02**
KW/TL (mg/mm) 16.160.6 21.861.1* 28.161.0** 28.960.9**
Body Fat Composition (%) 18.261.2 26.561.2* 69.162.1** 78.661.7*,**
Blood Glucose (mM) 5.5060.12 5.6060.21 5.7960.13 5.7960.20
HW = heart weight; LW = liver weight; KW = kidney weight; TL = tibial length; Mean 6 SEM, * p,0.05 vs. corresponding young group, ** p,0.05 vs. corresponding
C57 group, n=13 and 14 mice for C57 and ob/ob groups, respectively.
doi:10.1371/journal.pone.0010085.t001
Figure 1. Cumulative survival curve (Kaplan-Meier survival
plot) of male C57 lean and ob/ob obese mice. The cumulative
survival rate was plotted against age in months. The Log rank test was
performed to compare the two mouse groups (p=0.0007). n=26 and
16 mice for C57 and ob/ob mice, respectively.
doi:10.1371/journal.pone.0010085.g001
Figure 2. Light microscopic images of cardiomyocytes freshly
isolated from young (4-month-old) and aging (12- or 18-
month-old) lean (C57) and ob/ob mice. 200x, scale bar =100 mm.
doi:10.1371/journal.pone.0010085.g002
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reduced the intracellular Ca
2+ clearing rate (single and bi-
exponential decay) with no additive effect. Consistent with its
effect on cardiomyocyte shortening, there was little difference in
the aging-induced change in intracellular Ca
2+ property between
12 and 18 months of age. Furthermore, short-term leptin
supplementation at physiological levels (0.5 and 1.0 nM) signifi-
cantly attenuated or ablated intracellular Ca
2+ abnormalities in
young but not aging ob/ob mice. Consistent with its response in
cardiomyocyte shortening, short-term leptin treatment at physio-
logical levels (0.5 and 1.0 nM) failed to affect aging-induced
changes in intracellular Ca
2+ handling although pharmacological
level of leptin (50 nM) drastically interrupted cardiomyocyte
intracellular Ca
2+ homeostasis including elevated resting intracel-
lular Ca
2+ levels, depressed intracellular Ca
2+ rise in response to
electrical stimuli and prolonged intracellular Ca
2+ decay in both
young and aging C57 or ob/ob mouse groups (Fig. 4). Given that
12 and 18 months of age produced reminiscent mechanical
changes in C57 lean and ob/ob mice, 12 months of age was chosen
as the only aging group the remaining of ob/ob study.
Influence of age and ob/ob obesity on O2
2 production
and NADPH oxidase (p
47phox subunit) expression
Depending on the level of exposure, leptin is known to elicit a
paradoxical effect on cardiomyocyte contractile function through
either inhibition or stimulation of O2
2 production [22,22]. To
determine whether O2
2 production plays a role in the disparate
leptin effects between young and aging ob/ob mice, we evaluated
O2
2 production and expression of the rate-limiting enzyme for
O2
2 production NADPH oxidase (p
47phox subunit) [25] using DHE
Figure 3. Contractile properties of cardiomyocytes freshly isolated from young (4-month-old) and aging (12- or 18-month-old) lean
(C57) and ob/ob mice treated with or without leptin (0.5, 1.0 and 50 nM) for 4 hrs. A: Resting cell length; B: Peak shortening (PS, normalized
to cell length); C: Maximal velocity of shortening (+ dL/dt); D: Maximal velocity of relengthening (- dL/dt); E: Time-to-peak shortening (TPS); F: Time-to-
90% relengthening (TR90); Mean 6 SEM, n=50–53 cells from 3 mice per group, * p,0.05 vs. respective C57 group, ** p,0.05 vs. young C57 group,
# p,0.05 vs. respective ob/ob group.
doi:10.1371/journal.pone.0010085.g003
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suggested that obesity and aging (12-month) significantly enhanced
O2
2 production and upregulated expression of p
47phox NADPH
oxidase without an additive effect of the two. Leptin supplemen-
tation at physiological levels (0.5 and 1.0 nM) ablated obesity-
induced O2
2 production and p
47phox NADPH oxidase expression
in young but not aging ob/ob mice. Nonetheless, leptin treatment
at 0.5 and 1.0 nM failed to reconcile aging-induced effects on O2
2
production and p
47phox NADPH oxidase expression. Consistent
with the mechanical and intracellular Ca
2+ response, pharmaco-
logical level of leptin (50 nM) directly enhanced O2
2 production
and upregulated expression of p
47phox NADPH oxidase in both
young and aging C57 or ob/ob mouse groups (Fig. 5).
Influence of age and ob/ob obesity on leptin receptor
(Ob-R) and STAT3 activation
To determine the potential involvement of leptin signaling in
obesity and/or age-induced effects on cardiomyocyte contractile
function, intracellular Ca
2+ homeostasis and O2
2 production, we
evaluated the leptin receptor Ob-R, the post-leptin receptor
signaling molecule STAT-3 and STAT-3 phosphorylation. Our
results shown in Fig. 6 revealed that obesity, but not aging (12-
month), significantly reduced Ob-R protein expression and its
post-receptor signaling STAT-3 phosphorylation without affecting
the total STAT-3 expression. Interestingly, short-term leptin
supplementation at both 1.0 nM and 50 nM significantly
upregulated Ob-R expression in young but not aging ob/ob mice
and stimulated STAT-3 phosphorylation in both young and aging
ob/ob groups. Leptin treatment at 1.0 and 50 nM did not alter the
expression of Ob-R and STAT-3 in lean mice although the high
but not the low concentration of leptin directly stimulated STAT-3
phosphorylation in lean mice.
Influence of age and ob/ob obesity on Akt, eNOS and
AMPK
A number of signaling molecules have been shown to participate
in obesity and aging-induced biological responses and regulation of
cardiac function, including Akt, the Akt downstream signal eNOS
and the cellular fuel AMPK [29,30]. We examined the expression
of Akt, eNOS, AMPK and their phosphorylation in young and
Figure 4. Intracellular Ca
2+ transient properties of cardiomyocytes freshly isolated from young (4-month-old) and aging (12- or 18-
month-old) lean (C57) and ob/ob mice treated with or without leptin (0.5, 1.0 and 50 nM) for 4 hrs. A: Resting intracellular Ca
2+
fluorescence intensity; B: Rise in intracellular Ca
2+ fluorescence intensity in response to electrical stimuli; C: Single-exponential Ca
2+ transient decay
rate and D: Bi-exponential Ca
2+ transient decay rate. Mean 6 SEM, n=36–38 cells from 3 mice per group, * p,0.05 vs. respective C57 group,
** p,0.05 vs. young C57 group, # p,0.05 vs. respective ob/ob group.
doi:10.1371/journal.pone.0010085.g004
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results revealed that either obesity or age independently dampened
the phosphorylation of Akt and its downstream signaling molecule
eNOS without affecting expression of Akt and eNOS. There was
no interaction between obesity and age on the phosphorylation of
Akt and eNOS. Short-term leptin treatment at physiological level
(1.0 nM) reconciled the reduced phosphorylation of Akt and
eNOS in young ob/ob, but not the aging mice. While obesity and
age alone failed to affect AMPK and its phosphorylation, the
combination of the two significantly attenuated AMPK phosphor-
ylation but not total AMPK expression. Short-term leptin
treatment at physiological level (1.0 nM) reduced AMPK phos-
phorylation in young ob/ob mice but not other groups. Short-term
leptin treatment at physiological level did not affect the expression
of non-phosphorylated Akt, eNOS and AMPK. Interestingly,
short-term treatment of leptin at pharmacological level (50 nM)
significantly suppressed the phosphorylation of Akt, eNOS and
AMPK in all mouse groups (with the exception of AMPK
phosphorylation in aging ob/ob group) without affecting the
expression of non-phosphorylated Akt, eNOS and AMPK (Fig. 7).
Figure 5. O2
2 production (Panel A) and p
47phox NADPH oxidase subunit expression (Panel B) measured by DHE fluorescence and
immunoblotting, respectively, in cardiomyocytes freshly isolated from young (4-month-old) or aging (12-month-old) lean (C57)
and ob/ob mice treated with or without leptin (0.5, 1.0 and 50 nM) for 4 hrs. Insets: Representative gel blots of p
47phox NADPH oxidase
subunit using specific anti-p
47phox antibody. GAPDH was used as the loading control. Mean 6 SEM, n=12–14 (Panel A) and 9–11 (Panel B) per group,
*p ,0.05 vs. respective C57 group, ** p,0.05 vs. young C57 group, # p,0.05 vs. respective ob/ob group.
doi:10.1371/journal.pone.0010085.g005
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JNK, ERK and IkB
To further examine the possible role of stress signaling pathways
in obesity, aging and leptin-induced cardiac responses, expression
of p38 MAP kinase, JNK, ERK and the NFkB inhibitor IkBa s
well as their phosphorylation were examined in young and aging
C57 lean and ob/ob mouse cardiomyocytes. Our results revealed
that both obesity and age significantly inhibited and stimulated
phosphorylation of p38 MAP kinase and JNK, respectively,
without affecting expression of total p38 MAP kinase or JNK.
There was no additive effect between obesity and age on the
phosphorylation of p38 MAP kinase and JNK. Short-term leptin
Figure 6. The leptin receptor Ob-R expression (Panel A) and phosphorylation of the leptin receptor downstream signaling molecule
STAT-3 (pSTAT3, Panel B) in cardiomyocytes freshly isolated from young (4-month-old) or aging (12-month-old) lean (C57) and ob/
ob mice treated with or without leptin (1.0 and 50 nM) for 4 hrs. Protein expression of Ob-R and pSTAT-3 was normalized to the loading
control GAPDH or total STAT-3, respectively. Insets: Representative gel blots of Ob-R, pSTAT-3 and STAT-3 proteins using specific antibodies. Mean 6
SEM, n=3 – 6 isolations, * p,0.05 vs. respective C57 group, # p,0.05 vs. respective ob/ob group.
doi:10.1371/journal.pone.0010085.g006
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induced changes in the phosphorylation of p38 MAP kinase and
JNK in young mice without affecting that in aging mice. Neither
obesity nor age affected expression of total and phosphorylated
ERK, although the combination of the two significantly reduced
ERK phosphorylation. Leptin at 1.0 nM reconciled the reduced
ERK phosphorylation in aging ob/ob mice without affecting any
other mouse groups. Expression of non-phosphorylated ERK was
unaffected by short-term leptin treatment at 1.0 nM. Our data
further revealed that either obesity or aging significantly enhanced
phosphorylation of IkB with no additive effect between the two.
IkB is an inhibitor of NFkB where enhanced IkB phosphorylation
removes its inhibition on NFkB). Similar to its effect on other stress
signaling molecules, short-term leptin treatment at physiological
level (1.0 nM) removed obesity-induced phosphorylation of IkBi n
young but not aging mice. Last but not the least, short-term
treatment of leptin at pharmacological level (50 nM) significantly
activated the stress signaling molecules p38, JNK, ERK and NFkB
(via enhanced phosphorylation of IkB) in all mouse groups without
affecting the expression of non-phosphorylated proteins (Fig. 8).
Influence of age and obesity on cardiomyocyte function
in high fat-induced and db/db obesity
To further elucidate the interaction between aging and obesity
on cardiac contractile function, we went on to examine the high
fat diet-induced and the leptin receptor mutant db/db obesity
models. A 16-week high fat diet feeding regimen was applied to
young (4-month-old) and aging (12-month-old) C57 mice. Both
young and aging mice were euglycemic (data not shown) and
displayed a comparable separation in body weight in response to
low and high fat diet feeding (Young: Low fat: 26.660.6 g vs. High
fat: 30.660.6 g; Aging: Low fat: 28.860.4 g vs. High fat:
32.760.4 g, n=4 mice per group). The resting cell length was
significantly greater in high fat diet and aging groups without any
additive effect between the two. Short-term leptin treatment
(1.0 nM) failed to affect resting cell length in either low or high fat
diet groups at both ages. Both high fat diet feeding and aging
independently and significantly reduced PS and 6 dL/dt,
prolonged TR90 without affecting TPS. There was no additive
or synergistic effect between the two on the mechanical responses.
Leptin supplementation (1.0 nM) failed to reconcile high fat diet
or aging-induced mechanical alteration in PS, 6 dL/dt and TR90.
Furthermore, leptin treatment (1.0 nM) did not alter any of the
mechanical indices tested (Fig. 9). Our further study using the db/
db obese model revealed a somewhat comparable euglycemic (data
not shown) body weight gain between C57 (4-month: 24.060.8 g;
12-month: 28.060.9 g; 18-month: 30.260.8 g) and db/db (4-
month: 48.262.0; 12-month: 56.762.3; 18-month: 59.962.9%,
n=4 mice per group, p,0.05 vs. corresponding C57 group) mice.
The resting cell length was significantly greater in db/db and aging
Figure 7. Panel A: Representative gel blots of total and phosphorylated Akt, eNOS and AMPK in cardiomyocytes freshly isolated
from young (4-month-old) or aging (12-month-old) lean (C57) and ob/ob mice treated with or without leptin (1.0 and 50 nM) for
4 hrs using specific antibodies; Panel B: Phosphorylation of Akt expressed as pAkt-to-Akt ratio; Panel C: Phosphorylation of eNOS
expressed as peNOS-to-eNOS ratio; and Panel D: Phosphorylation of AMPK expressed as pAMPK-to-AMPK ratio. Mean 6 SEM, n=
4 – 6 isolations, * p,0.05 vs. respective C57 group, ** p,0.05 vs. young C57 group, # p,0.05 vs. respective ob/ob group.
doi:10.1371/journal.pone.0010085.g007
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obesity and aging significantly reduced PS and 6 dL/dt,
prolonged TR90 without affecting TPS. Interestingly, aging and
db/db obesity exerted an additive inhibitory effect on PS and 6
dL/dt without affecting TR90 at 18 but not 12 months of age
(Fig. 10).
Discussion
The major findings of our current study revealed that increased
age mimicked leptin-deficient ob/ob obesity-induced changes in
cardiomyocyte contractile function, intracellular Ca
2+ homeosta-
sis, NADPH oxidase expression, O2
2 accumulation, Akt/eNOS
and stress signaling (p38, JNK and NFkB). Little additive or
synergistic actions were noted between aging and ob/ob obesity on
the above-mentioned parameters, with the exception of a rise in
intracellular Ca
2+. Short-term treatment of leptin at physiological
levels (0.5 and 1.0 nM) elicited a beneficial effect on cardiomy-
ocyte contractile and intracellular Ca
2+ responses in young but not
aging ob/ob mice whereas pharmacological level of leptin (50 nM)
compromised cardiomyocyte contractile function, intracellular
Ca
2+ handling, NADPH oxidase expression, O2
2 accumulation,
Akt/eNOS and stress signaling. The disparity between young and
aging mice in physiological leptin level-induced mechanical
responses was closely mirrored by an accumulation of O2
2 and
expression of NADPH oxidase (p
47phox), the enzyme responsible for
O2
2 production. Further scrutiny depicted that aging and obesity
independently decreased the phosphorylation of Akt and its
Figure 8. Total and phosphorylated protein expression of p38 MAP kinase, JNK, ERK and IkB in cardiomyocytes isolated from
young (4-month-old) or aging (12-month-old) lean (C57) and ob/ob mice treated with or without leptin (1.0 and 50 nM) for 4 hrs.
Panel A: Phosphorylation of p38 expressed as pp38-to-p38 ratio; Panel B: Phosphorylation of JNK expressed as pJNK-to-JNK ratio; Panel C:
Phosphorylation of ERK expressed as pERK-to-ERK ratio; and Panel D: Phosphorylation of IkB expressed as p IkB-to-IkB ratio. Insets: Representative gel
blots of total and phosphorylated p38, JNK, ERK and IkB proteins using specific antibodies. Mean 6 SEM, n=4–8 isolations, * p,0.05 vs. respective
C57 group, ** p,0.05 vs. young C57 group, # p,0.05 vs. respective ob/ob group.
doi:10.1371/journal.pone.0010085.g008
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phosphorylation as well as inhibited p38 phosphorylation without
overt interactions between the two. Consistent with its respon-
siveness to mechanical function, O2
2 production and p
47phox
expression, physiological levels of leptin effectively restored leptin
deficiency-induced changes in the phosphorylation of Akt, eNOS,
JNK, IkB and p38 in young but not aging ob/ob mice. These data
favor a role of post-insulin receptor signaling and stress signaling in
obesity-associated cardiac mechanical defects and O2
2 accumu-
lation. Our data did not favor a major role for the leptin receptor
(Ob-R), its post-receptor signal STAT-3, ERK or AMPK in
leptin-elicited beneficial effects in ob/ob obese mice. Given that
Figure 9. Contractile properties of cardiomyocytes isolated from young (4-month-old) and aging (12-month-old) male C57 mice fed
a low (10%) or high (45%) fat diet for 16 weeks. Cohorts of cardiomyocytes were treated with or without leptin (1.0 nM) for 4 hrs prior to
mechanical study. A: Resting cell length; B: Peak shortening (PS, normalized to cell length); C: Maximal velocity of shortening (+ dL/dt); D: Maximal
velocity of relengthening (- dL/dt); E: Time-to-peak shortening (TPS); F: Time-to-90% relengthening (TR90); Mean 6 SEM, n=50–51 cells from 3 mice
per group, * p,0.05 vs. respective low fat group, ** p,0.05 vs. young low fat group.
doi:10.1371/journal.pone.0010085.g009
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detrimental effects in cardiomyocytes, it appears that aging may
produce cardiac contractile and intracellular Ca
2+ defects
associated with O2
2 accumulation reminiscent of leptin-deficient
obesity through a mechanism(s) independent of interrupted leptin
signaling.
Development of obesity and its associated complications may be
attributed to multiple factors including genetic, dietary, environ-
mental and evolutionary components, although pinpointing each
specific influence has been rather difficult [1,3]. Although human
obesity is usually accompanied by hyperleptinemia [16], both
hypo- and hyper-leptinemia have been shown to induce obesity
due to interrupted leptin signaling and energy expenditure [31].
Sustained obesity (diet-induced or genetically predisposed) impairs
cardiac contractile function in a manner reminiscent of pre-
diabetic insulin resistance and full-blown diabetes [32–35],
indicating a role for insulin resistance in obesity-induced cardiac
contractile dysfunction. This is supported by our current
Figure 10. Contractile properties of cardiomyocytes isolated from young (4-month-old) and aging (12- or 18-month-old) male C57
lean and the leptin receptor-deficient db/db obese mice. A: Resting cell length; B: Peak shortening (PS, normalized to cell length); C: Maximal
velocity of shortening (+ dL/dt); D: Maximal velocity of relengthening (- dL/dt); E: Time-to-peak shortening (TPS); F: Time-to-90% relengthening (TR90);
Mean 6 SEM, n=102–103 cells from 3 mice per group, * p,0.05 vs. respective C57 group, ** p,0.05 vs. young C57 (4-month) group, # p,0.05 vs.
young db/db (4-month) group.
doi:10.1371/journal.pone.0010085.g010
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aging ob/ob mice. In our study, the leptin deficient ob/ob mice were
euglycemic at both ages, thus excluding possible contribution from
full-blown diabetes to the cardiac anomalies of the ob/ob mice. Our
data revealed a somewhat similar tibial length among young and
aging C57 or ob/ob mice, excluding the possible contribution of
disparate growth and development in these mice. These data are
in line with the notion that tibial length reached plateau when
body growth slowed down after postnatal day 70 in mice [36].
Nonetheless, these ob/ob mice were hyperinsulinemic, hypertri-
glyceridemic and glucose intolerant based on our earlier studies
[12,14], indicating the presence of insulin resistance. More
importantly, our DEXA study depicted an age-dependent increase
in body fat composition in both C57 lean and ob/ob obese mice,
favoring aging itself as an independent obesogenic factor [4]. Data
from our study indicated that aging itself produced a cascade of
cardiomyocyte mechanical defects reminiscent of young ob/ob or
db/db as well as high fat diet-induced obese mice. In all three
murine obesity models used in our study, both aging and obesity
independently triggered an elongation in resting cell length,
depression in peak shortening (PS) amplitude and maximal
velocity of shortening/relengthening amplitude (6 dL/dt), as well
as prolongation in relengthening duration (TR90) but not duration
of shortening (TPS). These data are consistent with our previous
observations from aged or obese mice [14,37,38]. Interestingly,
there was little interaction between aging and obesity on
cardiomyocyte contractile parameters with the exception of
further depressed PS and 6 dL/dt in 18-month-old db/db mice.
These data seem to favor the notion that aging and obesity may
share somewhat similar cellular mechanisms en route to cardiomy-
ocyte mechanical dysfunction. The apparent disparity between ob/
ob and db/db mice on the synergistic effect of aging (18 months)
and obesity depicts presence of an overt age-related difference
between the two leptin mutant murine obesity models. Thus
caution should be taken to derive experimental conclusions using
various rodent obesity models. Given our further observation that
physiological leptin treatment failed to reconcile high fat diet- or
age-induced detrimental effects in cardiomyocytes, the conver-
gence between aging and obesity in cardiac contractile and
intracellular Ca
2+ defects as well as O2
2 accumulation likely
occurs at a point downstream of or independent of leptin signaling.
The Kaplan-Meier survival curve (Fig. 1) revealed a greatly
elevated mortality in ob/ob mice, supporting the hypothesis that
obesity may be considered a status of premature aging [4]. It is
worth mentioning that the 12 or 18 months of age selected for our
‘‘aging’’ mice was not as old as other studies have used. However
the mortality rate of ob/ob mice after one year of life is much
higher than other mouse types [26,38]. Although limited
information is available for the precise cause of death for these
ob/ob obese mice, it may be speculated that obesity-associated
tumorigenesis (e.g., colon and skin cancer), chronic inflammation,
immune deficiency and cardiovascular complications are among
the leading causes of death in these mice [39]. In our study, the
young and aging ob/ob mice exhibited significantly greater fat
composition, heavier body and heart weights compared with the
age-matched lean control group. Moreover, the aging ob/ob mice
displayed an additional increase in body weight compared with the
young ob/ob mice. Considering the comparable cardiomyocyte
functional profiles between young and aging ob/ob mice, it appears
that the extra body weight gain and body fat composition in aging
ob/ob mice had little effect on cardiac dysfunction associated with
obesity. Nonetheless, the additional increase in body and fat mass
was mirrored by a drop in the rise of intracellular Ca
2+ seen with
aging. The greater cardiomyocyte cell length in ob/ob mice at both
ages was not affected by short-term physiological leptin treatment,
likely due to the fact that cardiac hypertrophy resulting from
interrupted leptin signaling in ob/ob mice is a chronic process
[23,40]. During the chronic cardiac remodeling process with
interrupted leptin signaling, the heart transforms from compen-
sated to decompensated states accompanied by deteriorated
cardiac function.
Our study revealed that both aging and obesity impaired
intracellular Ca
2+ handling shown as delayed intracellular Ca
2+
clearance and reduced intracellular Ca
2+ rise, consistent with our
previous studies [14,37,38]. Unlike the observation from cardio-
myocyte mechanical assessment, the obesity-induced decline in
intracellular Ca
2+ release was further accentuated with aging,
indicating a possible change in myofilament Ca
2+ sensitivity in the
aging ob/ob murine cardiomyocytes. These observations favor the
idea that dysregulated intracellular Ca
2+ regulation may contrib-
ute to cardiomyocyte contractile dysfunction (prolonged TR90,
reduced PS and 6 dL/dt) under aging, obesity or both. Our data
further revealed that physiological leptin reconciled intracellular
Ca
2+ mishandling in young but not aging ob/ob mice, indicating
that intracellular Ca
2+ handling may contribute to the beneficial
mechanical response of leptin in young ob/ob mice. Our
observation of elevated O2
- production and upregulated p
47phox
subunit of NADPH oxidase in both aging and obese groups
(without interaction between the two) suggests a likely role of
NADPH oxidase-dependent O2
2 release in aging and/or obesity-
elicited cardiomyocyte intracellular Ca
2+ handling and contractile
dysfunction. The NADPH oxidase-dependent O2
2 production
and other reactive oxygen species are known to cause cardiomy-
ocyte mechanical dysfunction [22,25]. The fact that physiological
leptin alleviated obesity-elicited increases in O2
2 production and
p
47phox expression in young but not aging ob/ob mice favors a role
for NADPH oxidase-dependent O2
2 production in the disparate
cardiac response of short-term leptin treatment. Our further
observation in Ob-R expression and STAT-3 phosphorylation
depicted reduced Ob-R expression and STAT-3 phosphorylation
in both ob/ob age groups. To our surprise, unlike its effect on
cardiomyocyte contractile function, intracellular Ca
2+ homeostasis
and O2
2 production, leptin treatment restored downregulated
Ob-R expression and STAT-3 activation in both ob/ob age groups
without any effect in lean groups. These data indicate that the
likely mechanism responsible for the age-dependent disparity of
cardiac leptin responses may not reside at the levels of the Ob-R
or STAT-3. This notion received further support from our
observation that the pharmacological concentration of leptin
(50 nM) promoted Ob-R/STAT-3 signaling while compromis-
ing cardiomyocyte contractile function, intracellular Ca
2+
handling, NADPH oxidase expression, O2
2 accumulation,
Akt/eNOS and stress signaling. Data from our previous study
revealed that pharmacological levels of leptin (50 and 100 nM)
compromised cardiac contractile function and intracellular Ca
2+
homeostasis through an ET-1 receptor-/NADPH oxidase-
dependent accumulation of reactive oxygen species [22]. Our
current data revealed unchanged Ob-R (long form) expression
and reduced STAT-3 activation in murine hearts at 12 months
of age. Limited information is available with regards to aging-
induced changes in Ob-R expression and STAT-3 activation.
The leptin-induced STAT-3 phosphorylation was found to be
higher along with an upregulated hypothalamic expression of
the Ob-R at 14 - 18 months of mouse age compared with 2
months of age [41], indicating increased leptin sensitivity with
aging in the mouse brain. However, little information is
available on the heart with regards to the impact of aging on
leptin sensitivity.
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depressed the phosphorylationo fA k ta n de N O S ,s t i m u l a t e d
JNK and IkB phosphorylation as well as inhibited p38
phosphorylation without overt interaction between the two.
Meanwhile, leptin supplementation at physiological levels
rescued the dampened Akt/eNOS/p38 phosphorylation in
young ob/ob mice, the effect of which was obliterated by aging.
These data are consistent with the basal and leptin-elicited
responses on cardiomyocyte contractile function, intracellular
Ca
2+ handling, O2
2 production and NADPH oxidase expres-
sion. Under-activation of the key cardiac survival factor Akt and
its downstream signaling molecule eNOS has been demonstrat-
ed in various models of cardiac dysfunction and heart failure
[14,34], suggesting a crucial role of Akt/eNOS in the
maintenance of cardiac function. It is noteworthy that the
dampened Akt/eNOS phosphorylation observed in our ob/ob
mice may contribute to enhanced cardiac oxidative stress and
compromised cardiac function since the Akt-eNOS cascade is
known for its role in cardiac survival, glucose uptake and
maintenance of cardiac contractile function [30]. In our hands,
both obesity and aging independently decreased the phosphor-
ylation of Akt and eNOS without any additive effects between
the two, consistent with our data on mechanical, intracellular
Ca
2+ and O2
2 production. These observations favor a key role
for Akt/eNOS signaling in leptin-deficient obesity and age-
induced cardiac dysfunction. Our data revealed reduced p38
MAP kinase phosphorylation in aged and obese mice, while
leptin effectively restored p38 phosphorylation in young ob/ob
but not aging mice. These results favor a beneficial role of p38
phosphorylation in the maintenance of cardiomyocyte function,
which is supported by the previous finding that inhibition of p38
MAP kinase reduces insulin sensitivity and glucose uptake in
human myotubes [42]. This is also in line with the finding that
leptin directly stimulates p38 MAP kinase phosphorylation
[43,44]. JNK and NFkB may be turned on by pro-inflammatory
cytokines and free fatty acids in aging and obesity, resulting in
interrupted insulin signaling and development of cardiac
dysfunction [45]. Our observation of enhanced phosphorylation
of JNK and IkB (which removes its inhibition on NFkB) in
aging and obesity are consistent with the reduced phosphory-
lation of Akt and eNOS. In addition, our results revealed that
neither obesity nor age significantly affected the total expression
and phosphorylation of ERK and AMPK. Interestingly,
combining obesity and age significantly attenuated phosphory-
lation of ERK and AMPK, the effects of which were ablated
and unaffected, respectively, by leptin treatment. Although we
a r eu n a b l et oo f f e ra n yp r e c i s ee xplanation for the combined
effect between age and obesity on ERK and AMPK at this time,
our data do not favor a significant role for ERK and AMPK in
the reminiscent cardiac defects between aging and obesity as
well as the disparity in the leptin cardiac responsiveness. Further
study is warranted to better address the interplay among various
cell signaling pathways such as sirtuin, a key signaling molecule
in longevity and lifespan [46], or RAGE, which plays a key role
in aging-associated cardiomyocyte dysfunction via NFkB
activation [47], in the aging- and obesity-associated cardiac
contractile dysfunction.
Experimental limitations: Although our study provided a likely
causal relationship among cardiac mechanical function, intracel-
lular Ca
2+ homeostasis, NADPH oxidase, O2
2 accumulation,
Akt/eNOS and stress signaling activation between aging and
obesity, caution should be taken for the interpretation of the
precise interaction between aging and obesity in cardiac
dysfunction in the human setting. First and foremost, the short-
term in vitro leptin incubation used in our study may not best
represent the in vivo longer term effect of leptin on phenotypic
changes in obesity. Oxidative modification of intracellular Ca
2+
handling proteins is known to contribute to altered cardiomyocyte
mechanics such as prolonged relaxation in obesity [37]. It may be
speculated that short-term incubation of physiological levels of
leptin may interrupt the oxidative processes (i.e. scavenging
reactive oxygen species) thus shifting the redox balance towards
reducing processes and promoting reactions to temporarily reverse
oxidative modification of Ca
2+ handling proteins. Nonetheless, this
may not truly reflect the physiological setting in vivo. In our study,
only male mice were used which ignored the important gender
disparity in obesity and aging [2]. In our cell isolation procedure,
butanedione monoxime was used to uncouple cardiomyocyte
contractile elements and maintain cell viability for a prolonged
period of time, which may unevenly alter the true in vivo
cardiomyocyte mechanics and thus bias cardiomyocyte function
from lean and ob/ob groups. Measurement of contractile
performance in isolated cardiomyocytes has been established to
provide a fundamental assessment of cardiac contractile function
in pathological states. However, as in any study of this nature,
caution needs to be taken when correlating our present cellular
findings to whole heart function, as the latter is composed of
heterogeneous cell types, including nerve terminals and fibroblasts,
as well as the connective tissue alluded to above. Furthermore,
cardiomyocytes beat at a high frequency in vivo as opposed to the
non-physiological slow pace (0.5 Hz) used in our study despite the
fact that a low frequency contraction is deemed as a ‘‘slow
motion’’ to maximally reveal the cell mechanical defect. Last but
not least, the long–form Ob-Rb receptor monoclonal antibody
used in our study may cross-act with the short-form leptin
receptors although the latter cannot turn on the full JAK-STAT
leptin signaling due to the absence of the essential box-2 motif.
In summary, data from our present study suggested that aging
and the leptin deficient ob/ob obesity compromise cardiac
contractile function and intracellular Ca
2+ homeostasis via
comparable mechanisms involving NADPH oxidase-dependent
O2
2 production, phosphorylation of Akt, eNOS as well as the
stress signaling molecules p38, JNK and NFkB. Our study further
revealed an age-associated disparity in physiological leptin level-
elicited responsiveness in cardiomyocyte contraction, intracellular
Ca
2+ handling and O2
2 production. Collectively, these data favor
a role for NADPH oxidase, O2
2 generation, Akt, eNOS and the
stress signaling molecules p38, JNK and NFkB, rather than Ob-R
and STAT-3, in the basal and leptin-elicited cardiac response
during aging and obesity. Our data further revealed both similarity
and disparity in aging-associated cardiomyocyte mechanical
response between ob/ob obesity and high fat diet-induced or the
hyperleptinemic db/db obesity. Given the lack of knowledge of
aging-induced changes in adiposity and leptin signaling, the
precise interplay between aging and obesity, and contribution of
leptin signaling and downstream stress signaling activation, if any,
to the cardiac contractile dysfunction in the state of concurrent
aging and obesity warrant further research.
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